{"nct_id":"NCT03608501","title":"A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation","status":"WITHDRAWN","status_verified_date":"2020-01","start_date":"2019-09-30","start_date_type":"ESTIMATED","primary_completion_date":"2021-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2023-05-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["TAK"]}